Prevalence of potentially inappropriate medications among newly treated patients with type 2 diabetes in UK primary care

Feb-24

AUTHORS : Andrea M Burden, Institiute fro Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich HCI H 407 Vladimir-Prelog-Weg4, 8093 Zürich, Switzerland, EMAIL; andrea.burden@pharma.ethz.ch

JOURNAL : British Journal ofClinical Pharmacology

REFERENCE: 2024;1-19

DOI : 10.1111/bcp.16018

Prevalence of potentially inappropriate medications among newly treated patients with type 2 diabetes in UK primary care

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study